Key result
Wireless pulmonary artery pressure monitoring cuts heart failure hospitalizations across trials and registries.
Why the study?
Wireless hemodynamic monitoring in heart failure patients allows volume assessment to assist management and avoid hospitalizations, motivating a review of the devices, mechanisms, and patient effects.
Does wireless hemodynamic monitoring reduce heart failure hospitalizations and improve clinical outcomes in patients with heart failure?
Does wireless hemodynamic monitoring reduce heart failure hospitalizations and improve clinical outcomes in patients with heart failure?
Wireless hemodynamic monitoring, particularly with implantable pulmonary artery pressure sensors like CardioMEMS, provides actionable early warning of volume overload that significantly reduces heart failure hospitalizations across both HFrEF and HFpEF populations when paired with preemptive management strategies.
Answers are grounded in this paper and cite their sources.
Supports integration of wireless PA pressure monitoring into HF pathways; leaves open optimal selection and long-term outcomes in routine care.
PURPOSE OF REVIEW: Wireless hemodynamic monitoring in heart failure patients allows for volume assessment without the need for physical exam. Data obtained from these devices is used to assist patient management and avoid heart failure hospitalizations. In this review, we outline the various devices, mechanisms they utilize, and effects on heart failure patients. RECENT FINDINGS: New applications of these devices to specific populations may expand the pool of patients that may benefit. In the COVID-19 pandemic with a growing emphasis on virtual visits, remote monitoring can add vital ancillary data. Wireless hemodynamic monitoring with a pulmonary artery pressure sensor is a highly effective and safe method to assess for worsening intracardiac pressures that may predict heart failure events, giving lead time that is valuable to keep patients optimized. Implantation of this device has been found to improve outcomes in heart failure patients regardless of preserved or reduced ejection fraction.
No takes yet. Share an insight, caveat, or question.
Lander et al. (2021) conducted a review in Heart failure (HFpEF and HFrEF). Wireless hemodynamic monitoring (including pulmonary artery pressure sensors such as CardioMEMS, intrathoracic impedance via CIEDs, and left atrial pressure sensors) was evaluated on Heart failure hospitalizations and clinical outcomes. Wireless pulmonary artery pressure monitoring (CardioMEMS) safely assesses intracardiac pressures and reduces heart failure hospitalizations by 33% to 62% across clinical trials and registries.
Synapse has enriched 10 related papers. Consider them for comparative context: